These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7687902

  • 1. [The molecular mechanism of the action of antiviral preparations in the adamantane series].
    Kiselev OI, Blinov VM, Kozeletskaia KN, Il'enko VI, Platonov VG, Chupakhin ON, Stukova MA, Karginov VA.
    Vestn Ross Akad Med Nauk; 1993; (3):10-5. PubMed ID: 7687902
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The mechanisms of the antiviral action of the bora-adamantane derivative preparation BG-12].
    Markushin SG, Sinitsyn BV, Ginzburg VP, Khaĭder AM, Klimov AI.
    Vopr Virusol; 1993; 38(3):122-6. PubMed ID: 8073750
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
    Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI.
    JAMA; 2006 Feb 22; 295(8):891-4. PubMed ID: 16456087
    [Abstract] [Full Text] [Related]

  • 8. [Parent and recombinant influenza virus A strains differing in the degree of remantadine sensitivity].
    Vodeĭko GM, Zazimko LA, Farashian VR, Zhdanov VM.
    Vopr Virusol; 1982 Feb 22; 27(2):214-8. PubMed ID: 7090347
    [Abstract] [Full Text] [Related]

  • 9. New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine.
    Shibnev VA, Garaev TM, Finogenova MP, Shevchenko ES, Burtseva EI.
    Bull Exp Biol Med; 2012 Jun 22; 153(2):233-5. PubMed ID: 22816091
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Rapid method of producing influenza A virus variants resistant to amantadine and remantadine and their primary characteristics].
    Vladyko AS, Shobukhov VM, Linitskaia GL, Galegov GA.
    Vopr Virusol; 1982 Jun 22; 27(4):426-32. PubMed ID: 7135921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of remantadine and amantadine on the interaction of influenza virus proteins with model lipid membranes].
    Kharitonenkov IG, El Karadaghi S, Fedorov AN, Zakomyrdin IuA, Tverdislov VA.
    Vopr Virusol; 1988 Jun 22; 33(1):22-6. PubMed ID: 3369145
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug resistance among influenza A viruses isolated in Italy from 2000 to 2005: are the emergence of Adamantane-resistant viruses cause of concern?
    Ansaldi F, Valle L, Amicizia D, Banfi F, Pastorino B, Sticchi L, Icardi G, Gasparini R, Crovari P.
    J Prev Med Hyg; 2006 Mar 22; 47(1):1-3. PubMed ID: 17061402
    [No Abstract] [Full Text] [Related]

  • 19. Demonstration of influenza virus reproduction stages sensitive to remantadine.
    Kozeletskaya KN, Yukhnova LG, Zhukova TY, Guskin YR, Golubev DB.
    Virologie; 1980 Mar 22; 31(1):13-9. PubMed ID: 7189620
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.